TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive National Academy Of Sciences To form Cancer Policy Board At NCI’s Request August 16, 1996
TCL Archive Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial October 31, 2014
TCL Archive UT Southwestern Simmons Cancer Center received $50 million from Simmons family. November 4, 2005
